Family of patient who died during a clinical trial receive a six figure settlement
BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e7793 (Published 15 November 2012) Cite this as: BMJ 2012;345:e7793- Clare Dyer
- 1BMJ
The family of a patient who died during a clinical trial at the Royal Marsden Hospital in London to test a five drug combination for treating testicular cancer has won a six figure sum in an out-of-court settlement.
Gareth Kingdon, 39, was the first patient to die from side effects during the multicentre TE23 trial, which was funded by the Medical Research Council to compare treatment of poor prognosis testicular cancer by five drugs instead of the standard three drug regime.
The family of another patient in the trial, 27-year-old Gary Foster, who was treated at University College London Hospital …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.